Search by Drug Name or NDC
NDC 42192-0374-60 Nicotinamide 100; 2; 850; 750; 50; 27 ug/1; mg/1; ug/1; mg/1; ug/1; mg/1 Details
Nicotinamide 100; 2; 850; 750; 50; 27 ug/1; mg/1; ug/1; mg/1; ug/1; mg/1
Nicotinamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acella Pharmaceuticals, LLC. The primary component is CHROMIUM; COPPER; FOLIC ACID; NIACINAMIDE; SELENIUM; ZINC.
Product Information
NDC | 42192-0374 |
---|---|
Product ID | 42192-374_2ab60950-553c-45c4-830a-03b60d9d7768 |
Associated GPIs | 78104920000320 |
GCN Sequence Number | 073170 |
GCN Sequence Number Description | lmefolate/B3/copp/Zn/sel/chrom TABLET 0.5-750 MG ORAL |
HIC3 | C6Z |
HIC3 Description | MULTIVITAMIN PREPARATIONS |
GCN | 37533 |
HICL Sequence Number | 041605 |
HICL Sequence Number Description | LEVOMEFOLATE CALC/NIACINAMIDE/COPPER/ZINC/SELENIUM/CHROMIUM |
Brand/Generic | Generic |
Proprietary Name | Nicotinamide |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Nicotinamide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 100; 2; 850; 750; 50; 27 |
Active Ingredient Units | ug/1; mg/1; ug/1; mg/1; ug/1; mg/1 |
Substance Name | CHROMIUM; COPPER; FOLIC ACID; NIACINAMIDE; SELENIUM; ZINC |
Labeler Name | Acella Pharmaceuticals, LLC |
Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Standardized Ch |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
NDC 42192-0374-60 (42192037460)
NDC Package Code | 42192-374-60 |
---|---|
Billing NDC | 42192037460 |
Package | 60 TABLET in 1 BOTTLE (42192-374-60) |
Marketing Start Date | 2021-05-25 |
NDC Exclude Flag | N |
Pricing Information | N/A |